BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 7705188)

  • 21. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.
    Smiler D; Soltan M; Albitar M
    Implant Dent; 2008 Sep; 17(3):236-47. PubMed ID: 18784524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric assay for the measurement of human bone marrow phenotype, function and cell cycle.
    Lund-Johansen F; Bjerknes R; Laerum OD
    Cytometry; 1990; 11(5):610-6. PubMed ID: 2379452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment filtration: a method for the accurate determination of flow cytometric kinetic data from bone marrow aspirates.
    Zbroja RA; Wass J; Vincent PC; Young GA
    Exp Hematol; 1986 Feb; 14(2):85-9. PubMed ID: 3943571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential analysis of animal bone marrow by flow cytometry.
    Martin RA; Brott DA; Zandee JC; McKeel MJ
    Cytometry; 1992; 13(6):638-43. PubMed ID: 1451595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of normal human bone marrow by flow cytometry.
    Blanc C; Legac E; Binet JL; Michel A; Debré P; Merle-Beral H
    Nouv Rev Fr Hematol (1978); 1991; 33(3):231-5. PubMed ID: 1956760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proposed reference method for peripheral-blood monocyte counting using fluorescence-labelled monoclonal antibodies.
    Hübl W; Tlustos L; Erath A; Andert S; Bayer PM
    Cytometry; 1996 Mar; 26(1):69-74. PubMed ID: 8809484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD 45 gating correlates with bone marrow differential.
    Rainer RO; Hodges L; Seltzer GT
    Cytometry; 1995 Jun; 22(2):139-45. PubMed ID: 7587745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics.
    Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L
    Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proliferative response of lymphocyte subpopulations differing in avidity for sheep red blood cells after stimulation with normal allogeneic and tumour cells.
    Matera L; Potter MR; Moore M
    Immunology; 1981 Dec; 44(4):765-72. PubMed ID: 6947964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Erythropoiesis in myelodysplastic syndrome detected by multiparameter flow cytometry].
    Jensen IM; Jensen PD; Hokland ME; Hokland P; Ellegaard J
    Ugeskr Laeger; 1995 Sep; 157(37):5092-6. PubMed ID: 7502376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T; Witzig TE
    Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow aspirate immunofluorescent and bone marrow biopsy immunoperoxidase staining of plasma cells in histologically occult plasma cell proliferative marrow disorders.
    Menke DM; Greipp PR; Colon-Otero G; Solberg LA; Cockerill KJ; Hook CC; Witzig TE
    Arch Pathol Lab Med; 1994 Aug; 118(8):811-4. PubMed ID: 7520228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity.
    Spyridopoulos I; Hoffmann J; Aicher A; Brümmendorf TH; Doerr HW; Zeiher AM; Dimmeler S
    Circulation; 2009 Oct; 120(14):1364-72. PubMed ID: 19770396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
    Pallis M; Syan J; Russell NH
    Cytometry; 1999 Dec; 37(4):308-13. PubMed ID: 10547616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.